4 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Divided Metacognition: when epistemic norms conflict (DIVIDNORM)
Date du début: 1 juil. 2011, Date de fin: 31 déc. 2016,
The present project aims to provide a naturalistic account of epistemic norms, and of the associated epistemic awareness in children and adults from different cultures. Epistemics norms (ENs) such as intelligibility, relevance, truth, coherence and consensus are dimensions on which mental contents can be evaluated for their contribution to knowledge acquisition. Although EN sensitivity is central ...
Voir le projet
4
Participants partenaires
TERMINÉ
Persistence of allergic sensitization (PAS)
Date du début: 1 déc. 2009, Date de fin: 30 nov. 2014,
"Allergic disorders are dramatically increasing in the western world over the past several years. Allergies are inappropriate immune responses directed against harmless environmental antigens. Upon primary allergen encounter B cells are induced to differentiate into IgE producing plasma cells. Mast cells and basophils are then sensitized by binding of allergen-specific IgE molecules to the high-af ...
Voir le projet
2
Participants partenaires
TERMINÉ
Euro-BioImaging - Research infrastructure for imaging technologies in biological and biomedical sciences (Euro-BioImaging)
Date du début: 1 déc. 2010, Date de fin: 31 mai 2014,
Euro-BioImaging brings together imaging technologies stretching from basic biological imaging with advanced light microscopy, in vivo molecular imaging of single cells to animal models up to the clinical and epidemiological level of medical imaging of humans and populations. Euro-BioImaging, in close consultation with its stakeholders, will address the imaging requirements of both biological and m ...
Voir le projet
44
Participants partenaires
TERMINÉ
Memory loss in Alzheimer disease: underlying mechanisms and therapeutic targets (MEMOSAD)
Date du début: 1 janv. 2008, Date de fin: 30 juin 2011,
"MEMOSAD aims at defining the molecular mechanisms of Abeta- and Tau-induced synaptotoxicity and at developing disease-modifying therapeutics for the prevention of memory loss in Alzheimer disease (AD). Insoluble aggregates of the two proteins provide the pathological hallmarks of this incurable brain disorder. Early stage AD is characterized by a remarkably pure impairment of declarative memory a ...
Voir le projet